同仁堂國藥(03613.HK)與同仁堂集團公司續訂租賃框架協議
格隆匯12月30日丨同仁堂國藥(03613.HK)發佈公告,由於現有租賃框架協議將於2019年12月31日屆滿,公司與同仁堂集團公司於2019年12月30日訂立截至2022年12月31日的續訂租賃框架協議。據此,同仁堂集團公司已同意租賃並促使北京同仁堂集團的其他成員公司租賃若干物業予集團的任何成員公司用於其生產及營運,以使集團任何成員公司可以進一步不時與北京同仁堂集團任何成員公司修訂或重續為期三年的現有租賃,惟受限於年度上限。
公告表示,集團預期,其將繼續從同仁堂集團公司進行租賃以滿足不時的集團未來業務需求。因此,公司與同仁堂集團公司已訂立續訂租賃框架協議,以列明條款的框架,而彼等可能據此簽訂若干租賃協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.